Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast Database and a Deep Learning Artificial Neural Network Model-Based Approach

Por um escritor misterioso
Last updated 29 março 2025
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
Full article: Bringing together scientific disciplines for collaborative undertakings: a vision for advancing the adverse outcome pathway framework
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
Frontiers From Causal Networks to Adverse Outcome Pathways: A Developmental Neurotoxicity Case Study
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
Identification of toxicity pathway of diesel particulate matter using AOP of PPARγ inactivation leading to pulmonary fibrosis - ScienceDirect
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
High throughput data-based, toxicity pathway-oriented development of a quantitative adverse outcome pathway network linking AHR activation to lung damages - ScienceDirect
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
High throughput data-based, toxicity pathway-oriented development of a quantitative adverse outcome pathway network linking AHR activation to lung damages - ScienceDirect
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
GitHub - UOSEST/Jeong-et-al-2019-CRT-ToxCast-AOP206
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast Database and a Deep Learning Artificial Neural Network Model-Based Approach
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
Frontiers A Case Study on Integrating a New Key Event Into an Existing Adverse Outcome Pathway on Oxidative DNA Damage: Challenges and Approaches in a Data-Rich Area
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
Toxics, Free Full-Text
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach
Jaeseong JEONG, PostDoc Position, Doctor of Philosophy, University of Seoul, Seoul, School of Environmental Engineering

© 2014-2025 praharacademy.in. All rights reserved.